Clinical trial
Testing Effectiveness of Navigation Interventions to Increase Uptake of Cascade Genetic Testing Among Relatives of Individuals Diagnosed With Hereditary Cancer Syndromes
NCT06927947 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Testing Effectiveness of Navigation Interventions to Increase Uptake of Cascade Genetic Testing Among Relatives of Individuals Diagnosed With Hereditary Cancer Syndromes
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 23, 2025
- Completion date
- September 30, 2026
- Enrollment
- 625 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hereditary malignant neoplasm, hereditary neoplastic syndrome